Pramoxine hydrochloride
[CAS# 637-58-1]

Identification

• Classification: Analytical chemistry >> Analytical reagent >> Ion chromatography reagent
• Name: Pramoxine hydrochloride
• Synonyms: 4-n-Butoxyphenyl gamma-morpholinopropyl ether hydrochloride
• Molecular Formula: C₁₇H₂₇NO₃.HCl
• Molecular Weight: 329.87
• CAS Registry Number: 637-58-1
• EC Number: 211-293-1
• SMILES: CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl

Safety Data

• Hazard Symbols: GHS07 Warning
• Risk Statements: H302-H315-H319-H335
• Safety Statements: P261-P264-P264+P265-P270-P271-P280-P301+P317-P302+P352-P304+P340-P305+P351+P338-P319-P321-P330-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Hazard Classification

Hazard	Class	Category Code	Hazard Statement
Acute toxicity	Acute Tox.	4	H302
Skin irritation	Skin Irrit.	2	H315
Eye irritation	Eye Irrit.	2	H319
Specific target organ toxicity - single exposure	STOT SE	3	H335

Discovery and Applications

Pramoxine hydrochloride is a topical local anesthetic commonly used to relieve itching, pain, and discomfort associated with minor skin irritations, insect bites, burns, hemorrhoids, and other dermatological conditions. It belongs to the class of anesthetics that act by blocking nerve signal transmission to reduce sensation in the applied area.

Pramoxine hydrochloride was first introduced in the mid-20th century as an alternative to other local anesthetics, with the goal of providing effective topical anesthesia while minimizing the risk of allergic reactions and systemic toxicity. Its chemical structure includes an ether linkage, which distinguishes it from other common local anesthetics and contributes to its low allergenic potential.

The mechanism of action of pramoxine hydrochloride involves reversible blockade of sodium channels on the neuronal cell membranes. By inhibiting sodium ion influx, pramoxine prevents depolarization and propagation of nerve impulses, leading to a localized numbing effect. This action helps reduce the sensation of pain and itching when applied topically.

Pharmacologically, pramoxine hydrochloride is characterized by rapid onset of action, typically within minutes after topical application, and a duration of effect lasting from 30 minutes to several hours depending on the formulation and site of application. It is commonly formulated as creams, lotions, gels, sprays, or wipes, often combined with other agents such as corticosteroids or antiseptics to enhance therapeutic outcomes.

Pramoxine hydrochloride has minimal systemic absorption when used topically, which contributes to a favorable safety profile. Adverse reactions are generally rare and mild, mainly limited to local skin irritation or allergic contact dermatitis in sensitive individuals. Unlike some other topical anesthetics, pramoxine hydrochloride has a low incidence of sensitization and is less likely to cause methemoglobinemia.

Clinically, pramoxine hydrochloride is used to manage symptoms associated with a variety of conditions including eczema, psoriasis, poison ivy exposure, anal and genital itching, and minor wounds. It is also found in many over-the-counter products formulated for itch relief and minor skin discomfort.

In summary, pramoxine hydrochloride is a topical local anesthetic with a rapid onset of action and low allergenic potential. It acts by blocking sodium channels to reduce nerve impulse conduction, providing effective relief from pain and itching in a variety of dermatological conditions. Its minimal systemic absorption and favorable safety profile support its widespread use in topical formulations.

References

1954. Tronothane Hydrochloride (Pramoxine Hydrochloride) in the Control of Pruritus. Postgraduate Medicine, 16(5).
DOI: 10.1080/00325481.1954.11711718

1981. Allergy to pramoxine (pramocaine). Contact Dermatitis, 7(2).
DOI: 10.1111/j.1600-0536.1981.tb03964.x

2023. β‐Lactoglobulin variants as potential carriers of pramoxine: Comprehensive structural and biophysical studies. Journal of Molecular Recognition, 36(11).
DOI: 10.1002/jmr.3052